Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2015; 114(06): 1099
DOI: 10.1160/TH15-09-0720
DOI: 10.1160/TH15-09-0720
T&H Insights
Platelet-derived microparticles in patients with high cardiovascular risk and subclinical atherosclerosis
Further Information
Publication History
Received:
11 September 2015
Accepted:
11 September 2015
Publication Date:
30 November 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/201506/lookinside/thumbnails/10-1160-th15-09-0720-1.jpg)
Insight on Suades et al. Thromb Haemost 2015; 114: 1310-1321.
-
References
- 1 Burnier L, Fontana P, Kwak BR. et al. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101: 439-451.
- 2 Suades R, Padro T, Alonos R. et al. High levels of TSP1+/CD142+ platelet-derived microparticles characterize young patients with high cardiovascular risk and subclinical atherosclerosis. Thromb Haemost 2015; 114: 1310-1321.
- 3 Lacroix R, Judicone C, Mooberry M. et al. The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost. 2013 Epub ahead of print.
- 4 Shantsila E, Montoro-García S, Gallego P. et al. Circulating microparticles: challenges and perspectives of flow cytometric assessment. Thromb Haemost 2014; 111: 1009-1014.